Ageing and C. difficile infection-The immune and gastrointestinal impact

Gastrointestinal Nursing

Volumn 9, Issue 4, 2011, Pages 42-47

  Banning, Maggi ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

Ageing; Antibiotics; C.difficile; Gut; Immune response; Older people

Indexed keywords

EID: 79956346896     PISSN: 14795248     EISSN: None     Source Type: Journal    
DOI: 10.12968/gasn.2011.9.4.42     Document Type: Article

References (34)

1. Andrew D, Aspinall R (2002) Age-associated thymic atrophy is linked to a decline in IL-7 production. Exp Gerontol 37(2-3): 455-63 (Pubitemid 34073564)
2. Aslam S, Hamill RJ, Musher D (2005) Treatment of Clostridium difficile-associated disease: Old therapies and new strategies. Lancet Infect Dis 5(9): 549-57 (Pubitemid 41196754)
3. Barbut F, Petit J (2001) Epidemiology of Clostridium difficileassociated infections. Clin Microbiol Infect 7(8):405-10
4. Barlett JG (2006) Narrative Review: The new epidemic of Clostridium difficile -associated enteric disease. Ann Intern Med 145(10): 758-64
5. Brandt LJ, Kosche KA, Greenwald DA et al (1999) Clostridium difficile-associated diarrhoea in the elderly. Am J Gastroenterol 94 (11): 3263-66
6. British National Formulary (2010) Issue 60, section 5.1.11, 359-60
7. Dial S, Delaney J, Barkun AM et al (2005) Use of gastric acidsuppressive agents and the risk of community-acquired Clostridium difficile- associated disease. JAMA 294(23): 2989-95 (Pubitemid 41817660)
8. D'Souza AL (2007) Ageing and the gut. Postgrad Med J 83(975): 44-53
9. Franceschi C, Bonafe M, Valnesin S (2000) Human immunosenescence: The prevailing of innate immunity, the failing of clonotypic immunity and the failing of immunological space. Vaccine 18(16): 1717-20 (Pubitemid 30109535)
10. Freeman J, Bauer MP, Baines SD et al (2010) The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 23(3): 529-49
11. Gardener EM, Murasako DM (2002) Age-related changes in type 1 and type 2 cytokine production in humans. Biogerontology 3(5): 271-90
12. Gerding DN, Johnson S, Peterson LR et al (1995) Clostridium difficile-associated diarrhoea and colitis. Infect Control Hosp Epidemiol 16(8):459-77
13. Ginaldi L, Stenberg H (2002) The immune system. In: Timiras P (ed) Physiological Basis of Ageing and Geriatrics. CRC Press, Boca Raton, FL.
14. Hoffman JC, Zeitz M (2002) Small bowel disease in the elderly: Diarrhoea and malabsorption. Best Practice & Research Clinical Gastroenterology 16: 17-26
15. Karlstrom O, Fyryklund B, Tullus K et al (1998) A prospective nationwide study of Clostridium difficile-associated diarrhoea in Sweden. The Swedish C.difficile Study Group. Clin Infect Dis 26(1): 141-5 (Pubitemid 28068168)
16. Knoop FC, Owens M, Crocker IC (1993) Clostridium difficile: Clinical disease and diagnosis. Clin Microbiol Rev 6(3): 251-65 (Pubitemid 23231208)
17. Lichtman SM (2001) Bacterial translocation in humans. J Ped Gastroenterol Nutr 33: 1-10 (Pubitemid 32706116)
18. Loo VG, Poirer L, Miller M et al (2006) A predominantly clonal multi-institutional outbreak of Clostridium difficileassociated diarrhea with high morbidity and mortality. N Engl J Med 353(23): 2200-4
19. Ludlam H, Brown N, Sule O et al (1999) An antibiotic policy associated with reduced risk of Clostridium difficileassociated diarrhoea. Age Ageing 28(6): 578-80 (Pubitemid 29535338)
20. MacDonald C, Killgore GE, Thompson A (2005) An epidemic, toxin gene-variant strain of Clostridium difficile. N Eng J Med 353(23): 2433-41 (Pubitemid 41770164)
21. McFarland LV (2005) Alternative treatments for Clostridium difficile disease: What really works. J Medical Microbiol 54(Pt 2): 101-11 (Pubitemid 40867993)
22. Moore WE, Moore LH (1995) Intestinal floras of populations that present a high risk of colon cancer. Appl Environ Microbiol 61(9): 3202-7
23. Musher DM, Logan N, Mehendiratta V et al (2007). Clostridium difficile colitis that fails conventional metronidazole therapy: Response to nitazoxanide. J Antimicrob Chemother 59(4): 705-10 (Pubitemid 47073405)
24. Nathan C (2002) Points of control in inflammation. Nature 420(8): 846-52
25. Office of National Statistics (2010). Clostridium difficile Deaths continue to decrease. http://www.statisticsgov.uk/cci/ nugget.asp?id=1735 (Accessed 24 August 2010)
26. Pawlec G, Hirokawa K, Fulop T (2001) Altered T-cell signaling in ageing. Mech Ageing Dev 122(14): 1613-17
27. Pepin J, Valiquette L, Cossette B (2005) Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 173(9): 1037-42
28. Price MF, Dao-Tran T, Garey KW et al (2007) Epidemiology and incidence of Clostridium difficile-associated diarrhoea diagnosed upon admission to a university hospital. J Hosp Infect 65(1): 42-6 (Pubitemid 44932971)
29. Rudensky B, Rosner S, Sonnenblick M et al (1993).The prevalence and nosocomial acquisition of Clostridium difficile in elderly hospitalized patients.Postgrad Med J 69(807): 45-7 (Pubitemid 23052769)
30. Starr J (2005) Clostridium difficile associated diarrhoea: Diagnosis and treatment. BMJ 331(7515): 498-501 (Pubitemid 41248134)
31. Stephen AM, Cummings JH (1980) The microbial contribution to faecal mass. J Med Microbiology 13(1):45-56
32. Surowiec, D. (2006) Past, present and future therapies for Clostidium difficile-asssociated disease. Ann Pharmacother. 40(12): 2155-63 (Pubitemid 44954434)
33. Triadafilopoulos G, Shah MH, Pothoulakis C (1991) The chemotactic response of human granulocytes to Clostridium difficile toxin A is age dependent. Am J Gastroenterol 86(10): 1461-5
34. Viscidi R, Laughton BE, Yolken R et al (1983) Serum antibody response to toxin A and B of Clostridium difficile. J Infect Dis 148(1): 93-100 (Pubitemid 13039317)